Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_assertion type Assertion NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_head.
- NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_assertion description "[In contrast, KRAS mutations were identified only in adenocarcinomas (17.5% vs 0%; P = .01), and a novel EGFR mutation was detected only in squamous cell carcinomas (0% vs 7.5%; P = .24).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_provenance.
- NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_assertion evidence source_evidence_literature NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_provenance.
- NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_assertion SIO_000772 24037752 NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_provenance.
- NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_assertion wasDerivedFrom befree-2016 NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_provenance.
- NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_assertion wasGeneratedBy ECO_0000203 NP1110712.RA_RoSdQ0jXh3HRwqTEO-CNIBJigw7d1CjyJI29HteTNg130_provenance.